IDEA Ideagen Plc

TIDMIDEA

RNS Number : 7929E

Ideagen PLC

14 February 2018

Ideagen PLC

("Ideagen", "the Company" or the "Group")

Issue of shares under the Share Incentive Plan and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 5,625 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the purchase of Ordinary Shares by a number of employees under the Company's Share Incentive Plan ("SIP"). The new Ordinary Shares were purchased at 115.5 pence each being the closing mid-market share price on Thursday 8(th) February 2018.

Application has been made to the London Stock Exchange for the 5,625 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 19(th) February 2018.

After Admission, the total number of Ordinary Shares in issue will be 200,228,920 and the total number of voting rights will therefore be 200,228,920. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

 
Ideagen plc                           01629 699100 
David Hornsby, Chief Executive 
Graeme Spenceley, Finance Director 
 
finnCap Limited                       020 7220 0500 
Stuart Andrews/Henrik Persson/James 
 Thompson (Nomad) 
Stephen Norcross (Corporate 
 Broking) 
 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEBLGDDXSBBGIX

(END) Dow Jones Newswires

February 14, 2018 02:00 ET (07:00 GMT)

Ideagen (LSE:IDEA)
Historical Stock Chart
From Mar 2024 to Apr 2024

Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2023 to Apr 2024